Abbott Laboratories will report earnings pre-market on January 22, with an earnings consensus of $1.04 per share. See why I ...
Bernstein analyst Lee Hambright lowered the firm’s price target on Abbott (ABT) to $135 from $138 and keeps an Outperform rating on the shares ...
International Assets Investment Management LLC reduced its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 99.1% during the 4th quarter, Holdings Channel reports. The fund owned 14,721 shares ...
Over the past year, many Abbott Laboratories ( NYSE:ABT ) insiders sold a significant stake in the company which ...
North Chicago-based Abbott announced last month it reached a settlement agreement with Dexcom over all outstanding patent disputes relating to their glucose monitoring products, which estimate blood ...
In a report released yesterday, Lee Hambright from Bernstein maintained a Buy rating on Abbott Laboratories (ABT – Research Report), with a ...